Executive Summary
=================

1. Health political background
------------------------------

Coronary heart disease (CHD) is one of the major causes of death and also ranks first with regard to costs of illness. Several factors (like age, sex, cholesterol, obesity or high blood pressure) increase the risk of CHD. The extent of coronary calcification may be an additional risk factor and is detected by computed tomography (CT) techniques, namely electron beam computed tomography (EBCT), which is seen as the reference standard, and multi-detector computed tomography (MDCT), which, however, is far more spread in Germany than EBCT. Examination costs in either case are not covered by the compulsory health insurance.

2. Scientific background
------------------------

CHD is equivalent to a circulatory disturbance of the heart, mostly because of decreased coronary artery diameters. These are caused by atherosclerotic plaques, which often calcify. There is a positive correlation between the amount of atherosclerotic plaque and the amount of calcification. However calcification cannot be seen as an indicator of plaque rupture which is the most common cause of acute myocardial infarction.

Despite massive scientific research the process of atherosclerosis is still not understood completely. Based on the correlation between the development of atherosclerosis and risk factors like age or overweight several risk models like the Framingham-Score or the PROCAM-Score have been developed over the last decades with the aim of carrying out therapeutic and preventive interventions in a more targeted way. However a considerable part of myocardial infarctions that occur in clinical praxis cannot be predicted by current risk models. One way to improve risk stratification may be achieved through the use of imaging techniques of the coronary vessels and the measurement of coronary calcification.

Coronary calcium can be detected by fluoroscopy, EBCT or conventional computed tomography. Calcium detection with fluoroscopy shows low accuracy and reproducibility. Because of low data acquisition time and therefore good imaging quality EBCT is seen as the reference standard of coronary calcium detection in published literature. Nevertheless with the introduction of MDCT also conventional computed tomography yields shorter scan times and better image quality.

For CHD risk assessment and decisions about further diagnostic and therapeutic interventions calcification has to be quantified. Different scoring models for quantification of coronary calcium have been developed. In the scoring model of Agatston \[[@R1]\] calcified areas \>1mm² and a density of \>130 HU are multiplied by a co-factor of 1 to 4 depending on the peak density of the calcification. This score - developed for the use with EBCT - is criticised because of the fact that minimal variations of density may have a great impact on the calcium score. Alternatively the volume or mass score may be used to quantify coronary calcifications. The volume score as described by Callister et al. \[[@R2]\] takes account of density variations of the tissue within one voxel (the smallest unit acquired by CT) through interpolation. At present, the optimization of coronary calcium scores for different CT is discussed.

3. Objectives
-------------

The objective of this report is first to determine if additional predictive information can be gained by the measurement of coronary calcification in asymptomatic risk populations, especially in the context of risk assessment through conventional risk models, second to compare EBCT and MDCT as tools for the detection of coronary calcium and third to investigate the cost effectiveness of coronary calcium detection in asymptomatic risk populations, especially with respect to Germany. Moreover ethical aspects are discussed.

4. Medical assessment
---------------------

### 4.1 Methods

The systematic literature research resulted in 1080 abstracts. 39 studies were included for medical assessment according to predefined selection criteria. 174 publications were used as background information. Five additional articles were added through hand search.

### 4.2 Results

For the assessment of the prognostic value of coronary calcium detection 32 studies were included. Of these eleven studies (MDCT: 3, EBCT: 8) showed limited transferability of the results regarding the overall population. 21 studies showed sufficient external validity, of which ten studies (MDCT: 1, EBCT: 9) mainly deal with the correlation of coronary calcium and several risk factors. Overall it is assumed that coronary calcium measurement yields additional information to traditional risk factors with respect to CHD risk. However no clear threshold or standard values can be identified. Interestingly Rumberger \[[@R4]\], who compare several calcium scoring models, see no superiority of one of the models above the other.

The 26 studies used as background information agree that a correlation between coronary calcium and risk factors might be possible. This background literature shows sufficient internal validity, but external validity is doubtful because of the problematic transferability of the results of an US population to a German population. The study of Hoff et al. \[[@R3]\] has to be pointed out of the 26 studies because of the high number of patients. In this study about 30,000 asymptomatic persons are tested on traditional and some non-traditional CHD risk factors.

Seven studies are included in the assessment of CT-methods, six of which deal with coronary calcium measurement with 4-row CT (4-MDCT), one study compares the results of a 16-row computed-tomography with an EBCT-measurement.

In the identified studies different examination protocols are used for MDCT. In contrast EBCT is manufactured only by one company, therefore the protocol of EBCT (which is seen as reference standard) is quite similar in all studies.

Limitations of the assessment exist due to the fact that only three studies examine an asymptomatic population - the target population of this HTA-report. The selection of the study population is of importance, as the variability between scores measured by EBCT and MDCT varies depending on the range of coronary calcification. The variability of calcium scores is higher in the lower range of scores and vice versa.

The effect on risk stratification and further clinical management of patients through the use of different coronary calcification measurement methods (EBCT vs. MDCT) is of practical relevance. There is no agreement in literature on whether risk stratification models created for EBCT may be used for patients examined with MDCT.

All four studies comparing Agatston score with volume score obtained on MDCT and EBCT found higher agreement between volume scores than between Agatston scores.

Variabilities between EBCT and MDCT measurements lie within the range of variabilities of repeated scanning on either EBCT or MDCT.

### 4.3 Discussion

Basically, current studies of sufficient external validity assume that coronary calcium measurement yields additional information compared with traditional risk factors for cardiovascular disease. Nevertheless, according to guidelines e.g. of the U.S. Preventive Services Task Force, the American College of Cardiology and the American Heart Association coronary calcium measurement is not recommended. The main reason lies in the insecurity if the risks of the consequences of a false result are higher than the benefits of patients undergoing an earlier preventive strategy. This is also valid given the fact that coronary calcium measurement results in better prognosis than an electrocardiogram. Although some of these critical points have been considered in recent studies important questions are still waiting for an answer. Especially the definition of the population that profits from coronary calcium measurement as a screening tool can not be expected within the near future. While it is agreed that not all people should be tested it is not clear who should be tested under respect of what risk model and what threshold should be taken into account. According to literature the assumption that a positive test result has an impact on patients\' lifestyle behaviour cannot be seen as proven.

Coronary calcium examination by EBCT and quantification of coronary calcification using the Agatston score is considered as the \"gold standard\". The question of comparability of the results of MDCT coronary calcium measurement with the results of EBCT arises because of the rapid technical process of MDCT and the higher number of MDCT available in Germany. The identified literature shows limitations with respect to the study population and the MDCT used. Study results are inconsistent. With respect to the calcium score the authors conclude that the volume score shows better correlation between EBCT and MDCT measurements. Nevertheless, the discussion on a standardised score still is in progress. Important factors for the use as a screening tool are stability and reproducibility of the calcium score measured. From the assessed publications no clear conclusion whether these requirements are met can be drawn.

5. Economic assessment
----------------------

### 5.1 Methods

The systematic literature research resulted in 1080 abstracts. Four studies were included for economic assessment according to predefined selection criteria. 22 publications were used as background information, 14 of which were added through hand search.

### 5.2 Results

In the context of CHD diagnosis coronary calcium measurement can be used as a triage instrument with the aim of performing coronary angiography - which is invasive and more expensive - only in persons with strong suspicion of having CHD. Further procedures like stress tests can be used in addition. Two studies investigate this question and conclude that EBCT as the first examination is most cost effective in comparison to conventional non-invasive stress tests as well as to coronary angiography.

Coronary calcium detection as a tool for better risk stratification appears to be only moderately cost effective. Risk assessment via Framingham-Score combined with EBCT in comparison to risk assessment via Framingham-Score alone does not seem to be cost effective for a low risk population (additional costs per quality adjusted life year amount to \$ 86,752). Within populations with moderate risk however cost effective results might be possible which is also indicated by another study.

Nevertheless these results are drawn from a very limited number of (available) studies. Also limitations within the studies and medical developments during the last years not considered in these studies should be taken into account.

### 5.3 Discussion

In Germany mainly MDCT is used for the detection of coronary calcification. Therefore the above mentioned results which only refer to the USA and coronary calcium detection by EBCT cannot directly be transferred to Germany. Important aspects when doing a model calculation for Germany are the selection of appropriate diagnostic and therapeutic pathways and an appropriate risk model. With respect to MDCT the utilization of standardised examination protocols has to be reviewed. Further findings are expected from the ongoing Heinz Nixdorf Recall Study in which also an economic evaluation is done.

6. Ethical aspects
------------------

### 6.1 Methods

Seven articles on ethical aspects could be identified, three of which were added by hand search.

### 6.2 Results

Several American authors criticise the fast dissemination of a new and still insufficiently evaluated technology. Moreover it has to be considered - from an economic as well as ethical point of view - that coronary calcium screening may often lead to follow-up costs, e.g. further examinations, which have to be borne by the compulsory health insurance. Some people assume that a positive test result may induce people to a more risk reducing behaviour but may also decrease quality of life by increased anxiety. However this cannot be seen as proven according to literature. Choosing aggressive marketing strategies and advertising calcium screening as \"health check\" appears ethically questionable. In this context several authors emphasize the role and responsibility of physicians in counselling their patients.

### 6.3 Discussion

Coronary calcium screening is fast, simple, comparatively painless and yields seemingly unambiguous, quantifiable results. All the more careful patient education regarding necessity and usefulness of coronary calcium measurement becomes a crucial factor.

7. Summary of the results and discussion
----------------------------------------

According to published literature it can be concluded that coronary calcium detection offers additional information compared with traditional risk factors and represents an appropriate tool for improving risk stratification with established risk models. Yet many questions remain unanswered. First adequate calcium score thresholds have to be determined (these should not be absolute values but be constituted by age and sex related percentiles), secondly it cannot be said at present which population groups gain most (\"risk thresholds\" have to be defined). Moreover all studies up to date only consider Framingham risk assessment so direct conclusions for a risk model suitable for European populations (e.g. the PROCAM-score) cannot be drawn.

The variability between coronary calcification measurements on EBCT (gold standard) and MDCT depends on the range of calcium-score as well as on the scoring method. Comparability of the two techniques is better when using the volume score for which however is less information with regard to risk stratification. Inconsistence within results may also be caused by the lack of standardization of coronary calcium detection with MDCT.

From an economic perspective coronary calcium detection for asymptomatic risk patients cannot fully be recommended. EBCT as a triage instrument preliminary to CHD diagnosis by coronary angiography appears to be cost-effective for patients with unclear symptoms. Yet - at least in low-risk populations - it is rather not cost-effective as a tool for improved risk stratification. These results however are based on four US American studies and cannot directly be transferred to Germany.

8. Conclusion
-------------

In conclusion measuring coronary calcification is a promising tool for improving risk stratification with established risk models. Nevertheless many questions remain unsolved concerning the targeted use in medical practice, particularly regarding European populations. According to the literature review performed in this HTA report no specific recommendations can be made at present with regard to which patient groups should be screened, which calcium-score thresholds should be applied und which scoring method should be used for MDCT calcium screening in Germany. Standardisation and quality control regarding technical standards and examination protocols nevertheless can be seen as prior objective. Important results regarding the prognostic value of coronary calcium measurement and cost effectiveness with respect to Germany may be expected from the Heinz Nixdorf Recall study. Further medical results also may be expected from the MESA study.
